FDA Inspection 1109009 — Labena d.o.o.
The FDA completed an inspection of Labena d.o.o. on September 24, 2019 in Ljubljana. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 24, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ljubljana (Slovenia)